The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Early reports from a recent study suggest that when it comes to a common cancer treatment, appointment timing may in fact be a very big deal. At a June meeting of the American Society of Clinical ...